Medtronic plc (NYSE:MDT) had a weak trading session and its shares were last down at $84.18, down -0.41% or -0.49 points. The trading data also revealed that the total net flow stood at $66.68 million as the shares had $105.66 million in upticks but lost $38.98 million in downticks. The up/down ratio was 2.71. This data is particularly important for the traders and speculators alike as it could also be used to gauge the strength of the momentum in the shares. During the past week, the shares have seen a change of -1.78% in the shares.The block trade data suggests an inflow of $65.01 million in upticks and an outflow of $1.05 million in downticks. The up/down ratio for the block stood at 62.07. The net money flow for this transaction was recorded at $63.96.
Medtronic plc has dropped 1.82% in the last five trading days, however, the shares have posted positive gains of 4.39% in the last 4 weeks. Medtronic plc is up 10.89% in the last 3-month period. Year-to-Date the stock performance stands at 9.94%.
Currently the company Insiders own 0.21% of Medtronic plc shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -4.03% . Institutional Investors own 82.76% of Medtronic plc shares. During last six month period, the net percent change held by insiders has seen a change of -5.04%. . On the companys insider trading activities,The officer (SrVP & Chief Scien, Clin, Reg) of Medtronic Plc, Kuntz Richard sold 49,905 shares at $82.6 on June 3, 2016. The Insider selling transaction had a total value worth of $4,122,153. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Medtronic plc (NYSE:MDT) witnessed a decline in the market cap on Friday as its shares dropped 0.53% or 0.45 points. After the session commenced at $84.58, the stock reached the higher end at $84.6 while it hit a low of $83.455. With the volume soaring to 5,518,212 shares, the last trade was called at $84.14. The company has a 52-week high of $86.31. The company has a market cap of $151,540 million and there are 1,801,043,300 shares in outstanding. The 52-week low of the share price is $55.54.
Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.